What is the K Number in FDA database for holo?
folzaex
Posts
-
-
See HTOO
SP = arround 10$
The same comes for HYSR -
The beast ist weaking up
-
The Only one green ticker in my Portfolio today
-
Weekly summary
GLYC Monday Tuesday Wednesday Thursday Friday
Opening Price N/A $2.43 $2.29 $2.35 $2.35
Last Trade N/A $2.25 $2.31 $2.28 $2.25
Price Change N/A -$0.09 +$0.06 -$0.03 -$0.03
Percent Change N/A -3.85% +2.67% -1.30% -1.32%
Day High N/A $2.50 $2.44 $2.35 $2.36
Day Low N/A $2.22 $2.26 $2.26 $2.23
Volume N/A 751,642 420,556 220,779 315,260 -
See you after 4$
-
Dr. Mariangela Simao, a WHO assistant director-general for vaccines, says the UN health agency’s assessment of the Bharat Biotech vaccine was "quite advanced” and officials hoped for a decision by mid-September.
-
I mean $
-
3,30€ per tipranks
-
Let’s go
-
8 min delay
-
Waiting……for beginning ofconference
-
Frozen ticker
-
Gevo Announces Plans for Hydrocarbon-Process Pilot Unit at Luverne Facility
ENGLEWOOD, Colo., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), announced that it plans to install an alcohol-to-hydrocarbon process pilot unit at its facility located in Luverne, Minnesota (the “Luverne Facility”). The pilot unit is being designed to produce market development quantities of sustainable aviation fuel (“SAF”), renewable premium gasoline, other renewable fuel products, as well as provide capability to supply market development quantities of chemical products. The installation is estimated to begin in Q3 2022 with startup demonstration production expected in Q4 2022.In addition, we expect to test and evaluate certain potential unit operations that may be incorporated into Gevo’s state-of-the-art Net-Zero 1 production facility that is expected to begin production in 2024 in Lake Preston, South Dakota. Installation of the pilot unit at the Gevo-Luverne facility is part of the plan to use the facility as a technology development and piloting site. The pilot unit will also be used in training of employees for Net-Zero 1 and other future projects.
“The work we do at the Luverne facility will be critical in establishing a smooth startup of Net-Zero 1 and future Net-Zero projects for ramping up capacity right out of the gate,” stated Dr. Paul Bloom, Chief Carbon & Innovation Officer of Gevo. Dr. Bloom continued, “We also plan to use the new pilot capability to support our robust pipeline of new renewable fuel and chemical projects in the future, which is also a first step in converting Luverne into a hydrocarbon facility. We couldn’t do that effectively without the support we’ve received from the City of Luverne and the State of Minnesota. We’re excited to bring more high-quality jobs to the area and to continue to be a part of the Luverne community.”
Agri-Energy, LLC, Gevo’s wholly-owned subsidiary that owns the Luverne Facility, rehired multiple former employees in the beginning of August, and is in the process of hiring additional employees to produce the isobutanol (IBA) that is the feedstock for the hydrocarbon pilot unit. Additional operations staff will be required for the hydrocarbon production, though a certain number cannot yet be attributed to it.
-
9% + in Germany
-
5% +++ in Germany
-
Upcoming Milestones Expectations
H2 2021: Report cohort topline results from the ongoing Phase 1/2 study for treatment of AML and report the study's topline results.
H2 2021: Commence Phase 1/2 study in Europe for the treatment of AML evaluating combination therapy of Annamycin + AraC.
H2 2021: Commencement of an investigator-funded, second Phase 1b/2 clinical trial of Annamycin in sarcoma lung metastases in Europe
SRGA
HYSR
GLYC
OCGN
OCGN
MBRX
GLYC
SRGA
OCGN
SRGA
SRGA
OCGN
OCGN
OCGN
OCGN
GEVO
GLYC
GLYC
MBRX
GLYC